Recommended NZ | Guide to Money | Gimme: Competitions - Giveaways

Lee: Brachytherapy Is Best Treatment For Prostate Cancer Patients

Contributor:
Fuseworks Media
Fuseworks Media

Low Dose Brachytherapy is the best treatment for Australian and New Zealand men diagnosed with prostate cancer according to visiting U.S. expert Dr Robert Lee.

Speaking at the 19th Annual Scientific Meeting of the Australasian Brachytherapy Group, held in Melbourne on the weekend, keynote speaker Dr Robert Lee, Professor of Radiation Oncology at Duke University in North Carolina, USA, and Past President of the American Brachytheraphy Group outlined the superiority of brachytherapy compared to other prostate cancer treatment options.

"Low Dose Brachytherapy (LDR) is a treatment with a long track record of efficacy that can be completed in 45 minute procedure. Patient recovery time is much less than those associated with radical surgery. Whilst the cure rate is similar compared to radical surgery, the risk of incontinence or sexual dysfunction is much less"

Approximately 190,000 men a year in USA are diagnosed with prostate cancer, with 25-30% of men treated for the condition choosing Low Dose Brachytherapy because of the superiority of the treatment compared to other options

"For a man looking to preserve his sexual function it's the method of choice" said Dr Lee.

1 in 10 men in New Zealand will experience prostate cancer in their life time with around 2,500 men diagnosed with prostate cancer every year. Many men choose radical prostatectomy surgery and endure the side effects involved, often unaware that alternative treatment options are available.

The highly sophisticated treatment, which involves the permanent implantation of tiny radioactive seeds directly into the prostate gland has been used in New Zealand for 10 years and there are increasing numbers of urologists and radiation oncologists offering this treatment to their patients. Dr Matthews of Prostate Implants NZ said that a recent analysis of Prostate Implants NZ brachytherapy patients had shown a very low recurrence rate of 6% at 8yrs, with less occurrences of impotence and urinary incontinence than surgery.

The treatment is suitable for men of any age in good health, whose cancer is still confined to the prostate gland. This is the same patient profile for prostate surgery, a procedure with the same cure rates as brachytherapy.

All articles and comments on Voxy.co.nz have been submitted by our community of users. Please notify us if you believe an item on this site breaches our community guidelines.